VI
Vivo Innovation Fund II Holdings, L.P. cut its BLSM stake below 5%
Vivo Innovation Fund II Holdings, L.P. reported owning 4.7% of BlossomHill Therapeutics, Inc. (BLSM) (1,493,740 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G